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defInItIons
Incidence: The number of new cases of a condition 
(e.g. dementia) per population at risk in a given period 
of time.
Prevalence: The proportion of the population found to 
have a particular condition (e.g. dementia) at a specific 
point (point prevalence) or over a given period (e.g. 12 
month prevalence).
Cohort effect: The effect of being born at about 
the same time, and therefore likely to have similar 
experiences and be exposed to the same events and 
similar risks.
Dementia: A neurological condition in which there 
is substantial decline in a person’s cognitive abilities 
(memory, executive function, language, etc.) from a 
previous higher level to the extent that the person 
is no longer able to independently perform everyday 
activities. Dementia has many causes.
Alzheimer’s disease: The most common cause of 
dementia due to a degenerative condition of the 
brain which presents clinically with a gradual and 
progressive loss of memory and other cognitive 
functions, usually in late life, and has a distinctive 
picture on neuropathology, characterised by the 
presence of amyloid plaques and neurofibrillary 
tangles.
Vascular dementia: The second most common type 
of dementia in which there is loss of cognitive function 
due to the presence of disease of blood vessels in 
the brain leading to damage to brain tissue from loss 
of blood flow or, less commonly, bleeding in the brain 
(generally referred to as stroke or mini-stroke).
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foReWoRd
I asked Professor Perminder Sachdev to write this 
publication because I believe it is important that 
Australians understand that the prevalence rates of 
dementia are not set in stone. 
Recent research evidence suggests that the 
prevalence rates of dementia may have declined. 
The causes of this decline are not well understood 
but it may be the consequence of a number of 
environmental factors including better education and 
health care.
It remains true however that there are significant 
health factors, such as diabetes and obesity, that may 
increase dementia prevalence rates in the longer term. 
As well, in spite of the decline in prevalence rates, 
the numbers of people with dementia will continue to 
increase with the ageing of the population.
A much higher priority needs to be given to 
epidemiological research that provides a basis for 
understanding the prevalence of dementia in Australia 
and gives a baseline for monitoring changes over 
time. It should be a matter of concern for those with 
a serious commitment to health policy that Australia 
has to draw on international studies to calculate our 
country’s prevalence rates on the basis of the aged 
structure of the population.
On a more positive note, Australia was the first 
country in the world to have a publicly-funded 
dementia risk reduction program, Your Brain Matters, 
which is administered by Alzheimer’s Australia with 
Commonwealth funding. I hope this new publication 
will encourage even more Australians to visit our 
website www.yourbrainmatters.org.au and follow 
the recommended action to improve their brain health.
It is essential that health policy makers responsible for 
preventive health policies make connections between 
physical and brain health. It is now well established 
that the risk of dementia is greater for people with 
diabetes, cardiovascular disease, obesity, HIV/AIDS, 
and smokers. It follows that health promotion activities 
relating to physical conditions and lifestyle should 
make the point that people might be able to doubly 
benefit from preventive health activities with improved 
brain health.
I’m grateful to Professor Sachdev, who is now Chief 
Medical Adviser to Alzheimer’s Australia, for preparing 
this publication. I hope it will serve to make people 
take a more serious interest in finding out more about 
the nature of dementia and its prevalence.
Ita Buttrose AO, OBE  
National President, Alzheimer’s Australia 
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eXecUtIVe  
sUmmaRY
The world-wide projections of the prevalence of 
dementia in the coming decades have been a source 
of great concern to health systems and societies 
around the world.  The World Alzheimer Report 2010 
(1) estimated that there were 36 million people 
with dementia in 2010, with an expected doubling 
every 20 years to nearly 115 million in 2050. These 
sobering figures are based on assumptions that the 
age-adjusted prevalence of dementia would remain 
constant and the population would continue to age at 
the current rate. 
The assumption that the incidence of dementia will 
remain stable is now being put into question. There 
is emerging evidence to suggest that the incidence 
of dementia in older individuals may be declining. 
It appears that this change may be recent and has 
possibly occurred only in the last one to two decades. 
It may also be restricted so far to high income 
countries, although data from low and middle income 
countries are lacking.  
The reasons for this change are not understood, but 
education, more stimulating environments and better 
control of vascular risk factors may have contributed.  
The data are still preliminary and more studies are 
needed to establish the extent of this change and 
understand its causes.  It should be noted that the 
decline is not large enough to offset the increase 
in prevalence of dementia due to the ageing of the 
population and therefore investment and efforts to 
develop better treatments and care for people with 
dementia need to continue.
 The fact that dementia rates are malleable is an 
encouraging finding but the reduction cannot be taken 
for granted as gains in population health can easily be 
lost if societies do not remain vigilant and continually 
proactive. These preliminary findings provide a strong 
argument for large scale Government investment in 
dementia-prevention strategies, which should start 
from early life.
BackgRoUnd
The world-wide projections of the prevalence of 
dementia in the coming decades have been a source 
of great concern to health systems and societies 
around the world. The World Alzheimer Report 2010 
(1) estimated that there were 36 million people with 
dementia in 2010, with an expected doubling every 
20 years to nearly 115 million in 2050. The economic 
cost of dementia was estimated to exceed 1% of 
GDP in 2010, and projected to grow (1). Nearly 60% 
of dementia sufferers now live in low and middle 
income countries (LMIC) in which health and social 
care systems are less well developed, and it is 
estimated that this proportion will rise to >70% by 
2050 in what are currently categorised as LMIC (1). 
These sobering figures are based on assumptions 
that the age-adjusted prevalence of dementia would 
remain constant and the population would continue 
to age at the current rate. Recent data from Europe 
and North America have challenged the first of these 
assumptions, i.e. the incidence of dementia will 
remain constant. 
There are a number of reasons why the incidence 
of dementia could possibly change. The two most 
common subtypes of dementia are Alzheimer’s 
disease (AD) and vascular dementia (VaD) which 
together account for nearly three-quarters of all 
dementia (2), with AD accounting for the majority. 
There are known risk factors for both disorders, 
some of which are modifiable and have indeed been 
modified in recent times. Moreover, the two disorders 
often overlap in older individuals, and some of their risk 
and protective factors are shared. If the knowledge 
about modifiable risk factors is accurate, there is no 
reason why the incidence of these disorders should 
remain constant.
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BackgRoUnd modIfIaBle RIsk  
factoRs foR Vad
The current concept of VaD, also referred to as Vascular 
Cognitive Impairment (VCI) (3) and Vascular Cognitive 
Disorder (VCD) (4), is broad and encompasses 
dementia caused by stroke as well as brain injury due 
to any other vascular disease, in particular small vessel 
disease which may otherwise go unnoticed clinically 
(5). Since stroke is an important cause of VaD, any risk 
factor for stroke is also a risk factor for dementia. In 
addition, a number of factors increase the risk of small 
vessel disease and thereby cognitive impairment  
and dementia. 
The modifiable risk factors for stroke have been 
extensively studied and are identified as hypertension, 
diabetes mellitus, insulin resistance or the metabolic 
syndrome, high cholesterol, smoking, excessive 
alcohol use, obesity, physical inactivity, high 
homocysteine levels and atrial fibrillation (6). There 
have been major advances in the identification 
and management of these risk factors in the last 
half century and this is evident in the changing 
epidemiology of stroke. Most studies of stroke 
incidence, largely conducted in high income countries 
(HICs), show a secular trend of decline into the mid-
1980s, although the trend appears to have plateaued 
thereafter and even reversed in some cases (7), with 
only an Australian study showing a decrease in stroke 
incidence in the mid-1980s (8). Several factors have 
contributed to this trend, which include better control 
of risk factors, early diagnosis and intervention and 
birth-cohort or period-cohort effects, such as foetal 
or early childhood health which is known to influence 
cardiovascular health (8). One can speculate that a 
reducing incidence of stroke will lead to reduced rates 
of VaD. There are, however, some counterbalancing 
factors. Firstly, the reduction in stroke has largely 
occurred in HICs, and the data from LMICs are either 
not available or suggest an opposite trend in some 
countries (7). Secondly, the mortality rate from stroke 
has also gone down (7), suggesting that there is an 
increasing number of survivors, with a significant 
proportion suffering cognitive impairment. Thirdly, 
stroke is more likely to cause cognitive impairment in 
older people and those with lower education, previous 
cognitive deficits, diabetes and atrial fibrillation, and 
those who have repeat strokes or transient ischaemic 
attacks (6). Fourthly, early intervention and effective 
rehabilitation after stroke can reduce the consequent 
disability, including the effects on cognition. There is a 
world-wide effort to prevent and effectively treat stroke 
(9), and prevent the recurrence of strokes (9), and 
one can anticipate that this will have an impact on the 
incidence of VaD as well. 
Stroke is of course not essential for the development 
of VaD, and other vascular disorders, in particular 
arteriosclerotic small vessel disease, are often 
implicated. A number of modifiable risk factors for 
these disorders have been identified (table 1), many of 
which overlap with stroke risk factors, and these can 
be the targets for primary and secondary prevention 
at both the individual and population levels. A recent 
consensus statement (5) made a number of evidence-
based recommendations in relation to this: treatment 
of hypertension, hyperglycaemia, hypercholesterolemia 
and atrial fibrillation, smoking cessation, moderation 
of alcohol intake, weight control and increased 
physical activity are well supported. There are other 
measures such as treatment of depression and the 
use of anti-oxidants and anti-inflammatory drugs 
that currently do not have sufficient supportive 
evidence for their contribution to reducing the risk 
of cerebrovascular disease. However, overall trends 
in public health suggest that vascular disorders are 
being better managed or prevented and this augurs 
well for VaD rates, at least in HICs. The only disturbing 
trend is the rising rates of diabetes, obesity and the 
metabolic syndrome in both developed and developing 
countries, which could negate the benefits of other 
improvements. This is discussed below.
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modIfIaBle RIsk  
factoRs foR ad
While late-onset AD, which is by far the most common 
cause of dementia, has a strong genetic basis, many 
modifiable risk factors have been identified from 
case-control and observational studies. They can be 
categorised as follows:
Vascular risk factors: 
Many of the risk factors for stroke and VaD also 
increase the risk for AD. Most of the evidence comes 
from observational studies, although intervention 
studies are beginning to provide evidence that optimal 
control of these factors may delay if not prevent 
dementia. The main focus has been on hypertension, 
diabetes, metabolic syndrome, high cholesterol, 
mid-life obesity and physical inactivity, although 
smoking has also been suggested as a risk factor (10). 
These factors may directly accelerate AD pathology, 
increase the vascular lesions in the brain that co-exist 
with AD or have other direct brain effects. Cognitive 
benefits from the management of these risk factors 
may therefore emanate through either of these 
mechanisms, as is suggested for the treatment of 
hypertension (11). In a recent review, it was concluded 
that these risk factors accounted for nearly 25% of the 
population attributable risk for dementia world-wide, 
and their optimal management could prevent 10-15% 
cases of dementia (12).
Cognitive and brain reserve: 
Repeated observation that high education protects 
an individual from developing dementia has led 
to the concept of brain reserve (13). From the 
conceptualization that a brain with high reserve is 
bigger and/or has greater morphological and metabolic 
complexity, there has been an increasing emphasis 
on cognitive reserve which emphasises functional 
rather than structural complexity. Proxy measures used 
to measure cognitive reserve have been education, 
intellectual abilities and complexity of occupation (14). 
By one estimate, high cognitive reserve halves the 
risk of dementia (15), and the population attributable 
fraction of education for dementia prevention is 
estimated at about 20% (12). Importantly, cognitive 
reserve is not static, and complex cognitive activity 
through the life span can preserve and enhance 
it, therefore protecting against cognitive decline 
and possibly dementia (14). The brain itself is 
morphologically and functionally plastic, and both brain 
and cognitive reserve are modifiable factors through 
complex cognitive activity. Interestingly, physical 
activity and large social networks have also been 
suggested to increase brain reserve. 
The fact that a high intellectual level, usually but 
not always reflected in high education, has been 
found to be protective in most longitudinal studies of 
cognitive ageing and dementia raises the question 
whether better educational opportunities and 
increasing complexity in society has had a beneficial 
effect through the 20th century. A reference should 
be made here to what has been called the Flynn or 
the Flynn-Lynn effect, which refers to the sustained 
increase in both fluid and crystallised intelligence 
scores that have been recorded in many parts of 
the world from 1930 onwards (16). This increase, 
reflected in the performance of successive cohorts 
every ten years or so, has been reported on most 
tests purportedly measuring intelligence, but also 
attention and memory, and applies to all ages and 
levels of ability. The rate varies between countries but 
most industrialized countries show the effect (17). 
Various explanations have been offered for the effect, 
with the most important being better schooling, test 
familiarity, a more stimulating environment during 
brain development and better nutrition (18). There 
is recent evidence, however, that the Flynn effect 
may be ending in developed nations. In Danish male 
conscripts, the average gain in IQ points was 3 per 
decade in the 60s and 70s but 2 points in the 1980s 
and 1.3 points in the 1990s (19). In some countries, it 
may even have reversed in the last decade or two (19). 
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Based on this evidence, one would expect that 
cohorts born later would have an advantage in terms 
of cognitive reserve and therefore a lower risk for 
dementia than their older counterparts.
The importance of physical exercise should be 
particularly emphasised as a protective factor. Exercise 
has a beneficial effect on a number of other risk factors 
such as obesity, diabetes and hypertension, and is 
important for maintaining bone and muscle mass 
and vitality in general. However, it also has a direct 
effect on brain function and animal work supports its 
positive effect on neurogenesis and brain reserve. 
Many molecular mechanisms underlying this are being 
explored. For example, aerobic exercise has been 
shown to stimulate the production of brain-derived 
neurotrophic factor, a protein that supports existing 
neurons and promotes the growth of new neurons, 
and resistance training assists in the production of 
insulin-like growth factor 1 which is part of a complex 
system that brain cells employ to interact with 
their physiologic environment and regulate neural 
development. 
  Nutritional factors:
Dietary factors have been reported to influence 
dementia risk. Of course, the role of diet in obesity 
and diabetes are self-evident, and these have been 
mentioned as risk factors in the sections above. 
The other dietary factor with consistent literature 
is moderate use of alcohol, which has a protective 
effect against cognitive decline and dementia (20). 
Being a teetotaller and drinking excessively are both 
disadvantageous in comparison. The evidence for 
a Mediterranean diet, fish consumption, fruit and 
vegetable consumption and the use of antioxidants 
is less consistent, as is that for lower levels of 
homocysteine and the use of folic acid and  
vitamin B12 (21). 
Other risk factors: a history of depression and 
traumatic brain injury must also be considered  
as risk factors (12), and both are modifiable  
at the population level through medical and  
legislative actions.
Table 1:  
Modifiable risk and protective factors for Dementia
VascUlar dementIa alZheImer's dIsease
1. Brain and cognitive reserve: 
education, occupation, 
complex mental activity, 
physical exercise.
1. Brain and cognitive reserve: 
education, occupation, 
complex mental activity, 
physical exercise.
2. Vascular risk factors: 
hypertension, diabetes 
mellitus, insulin resistance 
or the metabolic syndrome, 
high cholesterol, smoking, 
excessive alcohol use, obesity, 
physical inactivity, high 
homocysteine levels and atrial 
fibrillation.
2. Vascular risk factors: 
hypertension, diabetes 
mellitus, insulin resistance 
or the metabolic syndrome, 
high cholesterol, smoking, 
excessive alcohol use, obesity, 
physical inactivity, high 
homocysteine levels.
3. Stroke and transient 
ischaemic attack, including 
optimal treatment and 
rehabilitation.
3. Nutrition: Mediterranean 
diet, fish consumption, fruit 
and vegetable consumption, 
foods rich in antioxidants, 
moderate alcohol use, low 
homocysteine, reduced caloric 
consumption.
4. Other: depression, traumatic 
brain injury
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If the risk factors for dementia are indeed modifiable 
and appear to have changed in frequency over the 
last century, is this reflected in dementia rates? It 
is important to distinguish between prevalence and 
incidence rates in this context. In epidemiology, 
prevalence refers to the proportion of the population 
found to have a particular condition, in this case 
dementia, whereas incidence refers to the number 
of new cases that develop within a specified period 
divided by the population at risk. As the number of 
older people in society increases, the prevalence 
of dementia rises without necessarily any change 
in its incidence. Since the ageing of the population 
influences the prevalence of dementia, the answer to 
the question whether dementia risk is changing must 
be sought in age-specific incidence rates. Importantly, 
this change must be demonstrated in the same 
geographical region using identical methodology, as 
population and methodological differences can also 
lead to unreliable results. Unfortunately, there no 
suitable Australian data, but a number of European 
and North American studies have attempted to 
address this question, using both incidence and age-
specific prevalence rates. Incidence studies are more 
difficult to conduct as they involve following a large 
population of people without dementia over a number 
of years until a significant number develop dementia. 
Investigators therefore have often relied on prevalence 
studies at two different time points, after adjusting for 
any changes in the age structure of the population. 
European studies:
One of the earliest studies in this regard was the 
Lundby study (22) which examined the incidence of 
‘organic brain syndromes’, including multi-infarct and 
senile dementia, in the whole population of Lundby, a 
suburb of Gothenburg, Sweden over a 25 year period. 
This study reported a decreasing incidence between 
the periods 1947-57 and 1957-72. The data were re-
examined by the same authors a few years later (23), 
who then retracted this claim, stating that there was 
no statistically significant difference between the  
two periods.
A Spanish group reported age-specific prevalence 
rates from the Zaragoza region in two studies about 
7 years apart (24). The overall prevalence of dementia 
was not significantly different in the two studies, but 
the prevalence in men in the age group 70-84 was 
lower in the later study. Methodological differences 
could account for the variation as the time scale was 
too short to hypothesise cohort effects, although 
the authors did invoke the environmental hypothesis 
without suggesting which environmental factors had 
changed in 7 years.
There have been two other Swedish reports on this 
issue. Investigators from Gothenburg (25) examined 
population-based samples comprising several hundred 
70-year-old individuals in 1976-77 and 2000-01, and 
75-year-olds in 1976-77 and 2005-06, and found no 
cohort effects on dementia rates. Investigators in 
Stockholm (26) performed two cross-sectional surveys, 
the first in 1987-89 and the second in 2001-04, of 
people aged 75 and over in central Stockholm, and 
determined DSM-IIIR dementia prevalence. They 
also used survival data to calculate incidence rates. 
They found that while the prevalence of dementia 
was stable, the survival of dementia patients had 
increased, suggesting that the incidence may  
have decreased. 
The Rotterdam study (27) presented more 
methodologically rigorous data on this topic. It 
determined dementia incidence over 5 years in 
two sub-cohorts, the first starting in 1990 and the 
second in 2000, and noted that the incidence was 
marginally lower in the second cohort, albeit not 
statistically significant (rate ratio 0.75, 95% CI 0.56-
1.02). Mortality was lower in the second cohort, 
despite the fact that the prevalence of hypertension 
and obesity had increased. The incidence of stroke 
was lower in the 2000 cohort, possibly due to the 
higher use of antithrombotic and lipid-lowering 
drugs. The 2000 cohort had more education and also 
larger brain volumes and less cerebral small vessel 
disease. A limitation of the study was the relatively 
small number of dementia case in the 2000 
cohort, limiting statistical power and precluding the 
examination to dementia subtypes.
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A recent UK report was from the Medical Research 
Council Cognitive Function and Ageing Collaboration 
(MRC CFAS) (28). They performed their first dementia 
survey in individuals 65 years or older in 6 areas 
of England and Wales in 1989 – 94 (CFAS I) and 
repeated it twenty years later (2008-2011) in three of 
these areas (CFAS II). The sampling methods were 
comparable, albeit not the same. If the rates found 
in CFAS I were projected to CFAS II, after correcting 
for differences in population structure, the expected 
prevalence of dementia in 2011 was estimated to be 
8.1%. The real prevalence was in fact found to be 
6.5%, a decrease of 1.8%. Using these figures, the 
estimated number of people with dementia in the UK 
was 664,000 in 1991, and this figure was expected to 
rise to 884,000 by 2011. The actual number in 2011 was 
now estimated to be 670,000, a 24% reduction over 
the predicted figures. Sensitivity analyses suggested 
that the conclusion that later-born individuals had 
a lower risk of prevalent dementia was robust. The 
authors did not explore the possible reasons for this 
decline, but higher education levels and better control 
of vascular risk factors were suggested.
A Danish study (29) did not actually measure rates of 
dementia, but examined the health status of people 
in the early 90s. They compared the functioning of 
people in their early 90s who were born either in 
1905 or 1915. The 1915 cohort, aged 95 at the time 
of assessment, performed better in their cognition 
and ability to function independently than the 1905 
cohort, assessed at the age of 93. The physical health 
of the two cohorts was however very similar.  This 
was despite the fact that those born in 1915 were 
more likely to survive to the early 90s, and were 
two years older than the earlier cohort at the time of 
assessment. The study suggested that more people 
born later were surviving to older ages and with 
better mental function and, by inference, lesser risk of 
dementia. The authors did not find definitive causative 
factors but argued that a more intellectually stimulating 
environment for the later cohort was the likely factor.
North American studies:
The incidence of dementia disorders was examined 
over 25 years (1960-84) through the Rochester 
Epidemiology Program Project which has a records 
linkage system for the Rochester, Minnesota 
population in the United Sates (30). The overall age- 
and sex-adjusted incidence rates of dementia were 
relatively stable over time, except in individuals 
>85 years who showed an increase in this period. 
Dementia attributable to cerebral infarcts reduced from 
10% to 5% in this period, arguably due to decline in 
stroke in this period. The proportion of dementia due to 
undetermined aetiology also decreased, possibly due 
to improved diagnostic practices.
Two studies from the United States, while 
methodologically less rigorous, have suggested a trend 
toward declining rates of dementia. The first study (31) 
assessed individuals 65 and over in the National Long 
Term Care Surveys, drawn from Medicare enrolment, 
in 1982 and again in 1999. The prevalence of those 
with severe cognitive impairment had declined from 
5.7% to 2.9% in this period, attributed to a decline in 
mixed (VaD and AD) dementia but not AD dementia 
itself. The authors attributed the decline to better 
education and reduced stroke risk. The second study 
(32) used data from the Health and Retirement Study, 
a population-based longitudinal survey of US adults, 
to examine the cognitive status of individuals aged 70 
and over in 1993 and 2003 using a 35-point cognitive 
scale or a proxy report. They found that cognitive 
impairment was present in 12.2% in 1993 and 8.7% 
in 2002, but those with impairment had a more rapid 
decline in the later cohort. 
 
A study of incident AD from Chicago examined 
individuals ≥65 years old every three years from 
1997 to 2008 (33). The analyses included 1695 
participants, of whom 360 developed AD; there was 
no change in risk for AD over time (odds ratio  
= 0.970, 95% CI 0.902 -1.044).  
One study (34) compared age-adjusted and overall 
prevalence of dementia in African Americans aged 
≥65 years living in Indianapolis, USA in 1992 and 
2001. Using a two-stage assessment process, the 
overall prevalence of dementia was 6.75% and 
7.445% respectively, a non-significant difference.
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Table 2: Studies examining time trends in dementia prevalence and incidence
aUthors cItY, coUntRY maIn oBJectIVe PoPUlatIon 
stUdIed
maIn fIndIng
Hagnell et 
al, 1893 (22); 
Rorsman et al, 
1986 (23)
Lundby, Sweden Incidence of multi-
infarct and senile 
dementia in 1947-57 
and 1957-72
Whole population  
of Lundby
Re-examined data: 
no sig difference 
between two 
periods
Kokmen et al, 
1993 (30)
Rochester MN, USA Crude and age- and 
sex-adjusted rates of 
DSM-III dementia from 
1960 to 1984
Rochester MN 
population aged  
≥65 years, with  
record linkage
Dementia rates 
stable except in 
>85 who showed 
an increase
Manton et al, 
2005 (31)
USA national survey Severe cognitive 
impairment prevalence 
in people ≥65 from 
1982 to 1999
National long-term care 
interviews through 
Medicare enrolment
Severe cognitive 
impairment 
declined from 
5.7% in 1982 to 
2.9% in 1999
Lobo et al,  
2007 (24)
Zaragoza, Spain Dementia prevalence  
7 years apart in  
people >65
Two population based 
studies ZARADEMP-0 
(n=1080) and 
ZARADEMP-1 
(n=3715)
Prevalence 
5.2% and 3.9% 
respectively (n.s.); 
lower prevalence in 
later study in men 
aged 70-84
Langa et al, 
2008 (32)
USA national Cognitive impairment 
in people ≥70 in 1993 
and 2003
US Health and 
Retirement Study
Cognitive 
impairment rate 
12.2% in 1993 and 
8.7% in 2002; later 
group had faster 
decline
Hall et al,  
2009 (34)
Indianapolis, USA Dementia rates in 
African Americans in 
1992 and 2001
African Americans 
aged ≥65 living in 
Indianapolis
No difference 
in prevalence of 
dementia despite 
differences in 
medical history
Herbert et al, 
2010 (33)
Chicago, USA Incident AD every  
3 years from 1997  
to 2008
Population based; 1695 
individuals ≥65 years 
old evaluated
AD rates stable 
over time
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Schrijvers et al, 
2012 (27)
Rotterdam, 
Netherlands
Dementia incidence 
over 5 years in 2 
cohorts, starting 1990 
and 2000
Population based 
cohorts 1 (n=5727) and 
2 (n=1769)
Incidence 
marginally lower 
in2nd cohort (rate 
ratio 0.75; 95% CI 
0.56-1.02)
Wiberg et al, 
2013 (25)
Gothenburg, 
Sweden
Prevalence of dementia 
in 70 year olds in 1976-
77 and 2000-01
Population based; 
several hundred in 
each sample
No differences  
in rates
Qui et al,  
2013 (26)
Stockholm, Sweden Surveys of people ≥75 
in 1987-89 and 2001-04
Cross-sectional 
population based 
surveys
Prevalence 
stable, but later 
cohort had 
increase survival, 
suggesting lower 
incidence
Matthews et al, 
2013 (28)
6 and 3 regions in 
UK, respectively
Dementia surveys of 
≥65 in 1989-94 (CFAS I) 
and 2008-11 (CFAS II)
Population based 
surveys; some 
differences in 
methodology
Age-adjusted 
dementia rates 
8.1% in CFAS I and 
6.5% in CFAS II; a 
24% reduction
Christensen et 
al, 2013 (29)
Denmark Cohort effects on 
cognition and health 
over 10 years
Birth cohorts, born 
1905 and 1915, and 
assessed at ages 93 
and 95 respectively
1915 cohort 
cognitively & 
functionally better; 
similar in physical 
health
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Rates of 
neURoPathologY
Another approach to answer the question whether the 
incidence of AD is decreasing with time is to examine 
if the burden of Alzheimer-type neuropathology is 
showing a cohort effect. A recent Swedish study (35) 
compared amyloid deposition in the brains of 1599 
individuals who died at ages 65 or greater (mean 
age 82 ± 8 years) between 1972 and 2006 and were 
consecutively autopsied at the University Hospitals 
of Geneva. They found that the amyloid burden in the 
brain was related to the year of death, and decreased 
by 24% over the period over the period for the 
population of people without dementia. The reduction 
was particularly marked in the oldest age group; 
people aged ≥85 years in 2006 had less amyloid 
deposition than those aged 75-84 in 1972. This was 
despite the fact that the prevalence of dementia, and 
the other pathology of AD – neurofibrillary tangles 
– increased in the study population in this period, 
suggesting that the more recent cohorts coming to 
autopsy were in fact sicker. The authors concluded 
that “the brains of older individuals in 2006 were 
10 years younger from the point of view of amyloid 
deposition compared with people who died 30 years 
earlier.” (p. 330).
conclUsIons
The data, in particular from recent European studies, 
do suggest that the age-specific prevalence and, by 
inference, incidence of dementia and severe cognitive 
impairment may be declining in HICs. The CFAS study 
(28) suggests that this reduction may be substantial 
and enough to significantly mitigate, but not totally 
offset, the effect of ageing of the population on overall 
prevalence. However, the data thus far should be 
considered to be preliminary and more evidence must 
be accumulated. The data, if one takes the Lundby 
and Rochester studies into consideration, also suggest 
that this may be a recent phenomenon, although again 
there are limitations in the evidence available. The 
phenomenon may, additionally, be as yet restricted to 
HICs. It would be interesting to acquire similar data 
from LMICs to see if the pattern of change is related 
to the demographic cycle. It is not clear whether 
the reduction is due to changes in VaD and mixed 
dementia, or rates of AD are also going down.
It is important to understand the underlying reasons 
for the change. The Rotterdam and Danish data 
suggest that these cohort effects may be related to 
education and more stimulating environments in the 
early period of life. If this is the case, one can expect 
continuing improvement in rates over the next few 
decades, as seen in the Flynn effect, but with eventual 
levelling off or even a decline. There are of course a 
number of competing influences, in particular vascular 
risk factors, occurrence and optimal management 
of stroke, and physical inactivity that could influence 
the rates in either direction. As mentioned previously, 
rates of stroke declined in HICs up to the mid-1980s 
but there has since then been a levelling off. Rates in 
some LMICs may in fact be trending upwards. Rates 
of diabetes, obesity and the metabolic syndrome are 
increasing in many societies, while that of smoking 
have an opposite trend (36-39). These changes have 
not been reflected in cardiovascular health data from 
Western countries so far (36), but it may well be a 
matter of time. Ultimately, the trends could also impact 
on dementia rates.
The situation is therefore complex, but the immediate 
news from HICs is encouraging that dementia rates 
are modifiable and may be trending downwards. We 
need to further examine the reasons for these changes 
and try to exploit these for public health programs. We 
must also remain cognisant of the fact that a decline 
cannot be taken for granted as there are opposing 
factors in play as well. The overall message is that 
preventative public health and social strategies have  
an important role and governments should invest  
in such strategies as one major part of the fight  
against dementia. 
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